Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
Posted On Tuesday, June 03, 2025
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
Posted On Tuesday, June 03, 2025
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
Posted On Tuesday, June 03, 2025
Windtree Announces Plan for Cryptocurrency Treasury Policy
Posted On Tuesday, June 03, 2025
Fortrea to Present at the Jefferies Global Healthcare Conference
Posted On Tuesday, June 03, 2025
Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book
Posted On Tuesday, June 03, 2025
RESTEM to Present at the 2025 BIO International Convention
Posted On Tuesday, June 03, 2025
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
Posted On Tuesday, June 03, 2025
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
Posted On Tuesday, June 03, 2025
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
Posted On Tuesday, June 03, 2025
Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes
Posted On Tuesday, June 03, 2025
Trethera Secures New License, Strengthening TRE-515 Intellectual Property Portfolio and Extending Market Exclusivity to 2045
Posted On Tuesday, June 03, 2025
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
Posted On Tuesday, June 03, 2025
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
Posted On Tuesday, June 03, 2025
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
Posted On Tuesday, June 03, 2025
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
Posted On Tuesday, June 03, 2025
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
Posted On Tuesday, June 03, 2025
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
Posted On Tuesday, June 03, 2025
Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor
Posted On Tuesday, June 03, 2025
BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process
Posted On Tuesday, June 03, 2025
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
Posted On Tuesday, June 03, 2025
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
Posted On Monday, June 02, 2025
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
Posted On Monday, June 02, 2025
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
Posted On Monday, June 02, 2025
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
Posted On Monday, June 02, 2025

Print